改善AML患者的密集诱导化疗的长期结果
1Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
强化化疗为急性髓性白血病 (AML) 患者提供长期缓解. 未来的战略将新药和MRD监测结合起来,以改善结果和降低毒性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床试验 临床试验
背景情况:
- 强化化疗与全源性造血细胞移植实现长期缓解在近50%的急性髓性白血病 (AML) 患者.
- 优化治疗,包括"7+3"组合和新药,提高了疗效和耐受性.
- 老年患者和特定遗传亚组的不满意结果需要探索替代的,不那么密集的方法,如基于venetoclax的疗法.
研究的目的:
- 审查目前针对AML的密集化疗的现状.
- 讨论AML治疗优化的新兴策略和未来方向.
- 要突出AML的密集治疗方案正在进行的演变.
主要方法:
- 对急性髓性白血病的当前治疗方案和临床试验数据的审查.
- 分析新药和支持性护理对治疗结果的影响.
- 探索未来的治疗模式,包括MRD指导的策略和组合疗法.
主要成果:
- 强化化疗仍然是长期消除AML的主要治疗选择.
- 新型药物和改进的MRD检测正在改变密集治疗方法.
- 目前正在进行的临床试验正在调查新药的组合,剂量修改和MRD指导策略.
结论:
- 强化化疗,增强新药和支持性护理,为AML提供治愈潜力.
- 未来的AML治疗可能将涉及量身定制的创新策略,以提高疗效和降低毒性.
- 为了验证基于venetoclax的疗法等替代方法,需要进行随机比较.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.4K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:22Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333